This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Gan & Lee Pharmaceuticals. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fangkai Xue: Innovator in Insulin Derivatives
Introduction
Fangkai Xue is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin derivatives. His innovative work has the potential to impact diabetes treatment and management.
Latest Patents
Fangkai Xue holds a patent for an insulin derivative, showcasing his expertise and dedication to advancing medical science. This patent represents a crucial step in improving the efficacy of insulin therapies for patients.
Career Highlights
Fangkai Xue is currently employed at Gan & Lee Pharmaceuticals, a company known for its focus on diabetes care and innovative pharmaceutical solutions. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of Fangkai Xue's notable coworkers include Zhongru Gan and Wei Chen. Their combined efforts contribute to the ongoing research and development initiatives at Gan & Lee Pharmaceuticals.
Conclusion
Fangkai Xue's work in insulin derivatives exemplifies the importance of innovation in the pharmaceutical industry. His contributions are paving the way for advancements in diabetes treatment, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile